Recent Updates
Recently added Catalysts
BDX Positive Sentiment Score: 60/100

BD to Announce Financial Results for its Third Quarter of Fiscal 2023 BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results...

Key Takeaway: Becton, Dickinson and Company (NYSE: BDX) announced that it will release its financial results for the third quarter of fiscal 2023 on August 3, 2023. The announcement includes plans for a webcast discussion at 8 a.m. ET to provide insights into the company's operations and strategic direction. The results will reflect the fiscal period ending June 30, 2023, and corresponding materials will be accessible through its investor relations website.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is set to report its financial results, indicating transparency.
  • The company continues to showcase its commitment to healthcare innovation.
  • The audio webcast provides stakeholders with an opportunity for direct engagement.

Full Press Release Details

FRANKLIN LAKES, N.J. , July 6, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it will report financial results for its third quarter of fiscal year 2023 on Thursday, August 3, 2023 . A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors , along with related presentation materials. The news release and presentation materials will include summary financial information for the company's third quarter of fiscal year 2023, which ended on Friday, June 30, 2023 .
BD management will host an audio webcast at 8 a.m. ET on August 3, 2023 to discuss its financial results and provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the call at the same website.
About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo .
Contacts:
Media : Investors :
Troy Kirkpatrick Francesca DeMartino
VP, Public Relations SVP, Head of Investor Relations
858.617.2361 201.847.5743
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

When will BD report its Q3 2023 financial results?

BD will report its Q3 2023 financial results on August 3, 2023.

What time is the audio webcast for BD's financial results?

The audio webcast is scheduled for 8 a.m. ET on August 3, 2023.

Where can I find BD's financial news release?

The news release will be available at www.bd.com/investors.

What date marks the end of BD's fiscal Q3 2023?

BD's fiscal Q3 2023 ended on June 30, 2023.

How many employees does BD have worldwide?

BD employs approximately 77,000 people globally.

Last updated: Jul 6, 2023